Global Lupus Experts Recommend Changes to Clinical Trial Outcome Measures to Expedite Development of Therapeutics

/PRNewswire/ -- Lupus is a complicated and debilitating autoimmune disease, affecting millions of people across the globe. Yet, lupus drug development lags...

Related Keywords

Washington ,District Of Columbia ,United States ,America ,Joan Merrill ,Karenh Costenbader ,Anca Askanase ,Mike Donnelly ,Scientific Advisory Council ,Lupus Pillars For Health Advancement ,Lupus Program At Brigham ,Drug Administration ,Lupus Foundation Of America ,Eric Morand At Monash University ,Global Advisory Committee ,Addressing Lupus Pillars ,Health Advancement ,Project Global Advisory Committee ,Stakeholder Meeting ,Lupus Clinical Trial Outcome Measures ,Patient Perspective ,Lupus Science ,Lupus Foundation ,America Medical Scientific Advisory Council Chair ,Lupus Program ,America Rapid Evaluation ,Treatment Response Measure ,Eric Morand ,Monash University ,